● Recruiting

A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Condition: Radiation-induced Xerostomia · Sponsor: West China Hospital

PhasePhase 1/Phase 2

Planned participants58

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

This study is a single-center, double-blind, randomized controlled clinical trial with placebo as the control, aiming to evaluate the effectiveness of spermidine in preventing radiation-induced xerostomia during radiotherapy for head and neck tumors (including nasopharyngeal carcinoma).

This description comes directly from the study's public registry record.

Talk to the study team

Xingchen Peng · 18980606753 · pxx2014@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07035626